Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-24 Patel Ronil A. SVP, Operations & Bus. Dev. Grant or award · Employee Stock Option (right to buy) +30,000 30,000
2023-04-19 MANUSO JAMES S J Director Grant or award +2,819 57,828
2023-04-19 Benton Susan Director Grant or award +1,053 68,486
2023-04-19 Rodgers Richard J Interim CEO and President Grant or award +50,000 138,246
2023-04-19 Pepose Jay Director Grant or award +468 46,375
2023-01-11 MANUSO JAMES S J Director Grant or award +18,544 55,009
2023-01-11 Pepose Jay Director Grant or award +13,013 45,907
2023-01-11 Rodgers Richard J Director Grant or award +20,822 88,246
2023-01-11 Benton Susan Director Grant or award +16,267 67,433
2023-01-10 Sooch Mina President and CEO Grant or award +134,456 430,501
2023-01-10 Sooch Mina President and CEO Grant or award · Employee Stock Option (right to buy) +201,683 201,683
2023-01-10 Pepose Jay Director Grant or award · Stock Option (right to buy) +33,291 33,291
2023-01-10 Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. Grant or award +46,608 146,728
2023-01-10 Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. Grant or award · Employee Stock Option (right to buy) +69,912 69,912
2023-01-10 Zaremba Rabourn Amy SVP of Finance Grant or award +46,608 46,608
2023-01-10 Zaremba Rabourn Amy SVP of Finance Grant or award · Employee Stock Option (right to buy) +69,912 69,912
2023-01-04 Gallagher Cam Director Option exercise +1,574 $0.00 $0 24,928
2023-01-04 Gallagher Cam Director Option exercise · Series B Warrant (right to buy) −1,574 0
2022-10-19 Ainsworth Sean Director Option exercise +1,574 $0.00 $0 41,239
2022-10-19 Ainsworth Sean Director Option exercise · Series B Warrant (right to buy) −1,574 0

Page 9 of 15 · 283 trades